_id

6919e2053c536f8df2317f6e

Ticker

0RA2.LSE

Name

Poxel S.A.

Exchange

LSE

Address

Immeuble Le Sunway, Lyon, France, 69007

Country

UK

Sector

Industry

Currency

EUR

Website

https://www.poxelpharma.com

Description

Poxel S.A., a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the treatment of type 2 diabetes in Japan. It also develops PXL770, an adenosine monophosphate-activated protein kinase enzyme, which is in a Phase 2a clinical trial that treats chronic metabolic diseases, including diseases that affect the liver, such as non-alcoholic steatohepatitis (NASH); PXL065, an earlier stage programs that is in Phase 2 for the treatment of NASH focusing on chronic and rare metabolic indications. The company has a licensing agreement with Enyo Pharma S.A.S. for the development of farnesoid X receptor that is in Phase 2a study for the treatment of hepatitis B and NASH; and DeuteRx LLC for the development of PXL065, a mitochondrial dysfunction; and Sumitomo Pharma for development and commercialization of Imeglimin. Poxel S.A. was incorporated in 2009 and is headquartered in Lyon, France.

Last Close

1.6

Volume

4459

Current Price

0.2255

Change

0

Last Updated

2025-12-05T15:09:50.149Z

Image

https://logo.clearbit.com/www.poxelpharma.com

Ipo Date

-

Market Cap

39495520

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Current Quarter

2024-06-30

Revenue

1162000

Cost Of Revenue

1146000

Gross Profit

16000

Operating Expenses

3830000

Operating Income

-3814000

Interest Expense

3541000

Pretax Income

-7362000

Net Income

-7258000

Eps

-0.16876124295050363

Dividends Per Share

-

Shares Outstanding

24087900

Income Tax Expense

-104000

EBITDA

-3724000

Operating Margin

-328.22719449225474

Total Other Income Expense Net

-3548000

Cash

2812000

Short Term Investments

-

Receivables

829000

Inventories

-

Total Current Assets

5452000

Property Plant Equipment

22000

Total Assets

5588000

Payables

2313000

Short Term Debt

12377000

Long Term Debt

-

Total Liabilities

56160000

Equity

-50572000

Depreciation

96000

Change In Working Capital

1011000

Cash From Operations

-2860000

Capital Expenditures

0

Cash From Investing

64000

Cash From Financing

3267000

Net Change In Cash

471000

PE

-

PB

-0.19176999876413825

ROE

14.351815233726173

ROA

-129.88546886184682

FCF

-2860000

Fcf Percent

-2.4612736660929433

Piotroski FScore

1

Health Score

26

Deep Value Investing Score

0.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

4.3

Garp Investing Score

2.5

Growth Investing Score

2

Momentum Investing Score

2

Net Net Investing Score

0.5

Quality Investing Score

1

Value Investing Score

1.5

Quarters > 0 > quarter

2024-06-30

Quarters > 0 > income Statement > revenue

1162000

Quarters > 0 > income Statement > cost Of Revenue

1146000

Quarters > 0 > income Statement > gross Profit

16000

Quarters > 0 > income Statement > operating Expenses

3830000

Quarters > 0 > income Statement > operating Income

-3814000

Quarters > 0 > income Statement > interest Expense

3541000

Quarters > 0 > income Statement > pretax Income

-7362000

Quarters > 0 > income Statement > net Income

-7258000

Quarters > 0 > income Statement > eps

-0.16876124295050363

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

43007505

Quarters > 0 > income Statement > income Tax Expense

-104000

Quarters > 0 > income Statement > EBITDA

-3724000

Quarters > 0 > income Statement > operating Margin

-328.22719449225474

Quarters > 0 > income Statement > total Other Income Expense Net

-3548000

Quarters > 0 > balance Sheet > cash

2812000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

829000

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

5452000

Quarters > 0 > balance Sheet > property Plant Equipment

22000

Quarters > 0 > balance Sheet > total Assets

5588000

Quarters > 0 > balance Sheet > payables

2313000

Quarters > 0 > balance Sheet > short Term Debt

12377000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

56160000

Quarters > 0 > balance Sheet > equity

-50572000

Quarters > 0 > cash Flow > net Income

-7258000

Quarters > 0 > cash Flow > depreciation

96000

Quarters > 0 > cash Flow > change In Working Capital

1011000

Quarters > 0 > cash Flow > cash From Operations

-2860000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

64000

Quarters > 0 > cash Flow > cash From Financing

3267000

Quarters > 0 > cash Flow > net Change In Cash

471000

Quarters > 0 > ratios > PE

-0.16876124295050363

Quarters > 0 > ratios > PB

-0.19176999876413825

Quarters > 0 > ratios > ROE

14.351815233726173

Quarters > 0 > ratios > ROA

-129.88546886184682

Quarters > 0 > ratios > FCF

-2860000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-2.4612736660929433

Quarters > 0 > health Score

26

Quarters > 1 > quarter

2023-12-31

Quarters > 1 > income Statement > revenue

1026000

Quarters > 1 > income Statement > cost Of Revenue

1025000

Quarters > 1 > income Statement > gross Profit

1000

Quarters > 1 > income Statement > operating Expenses

5701000

Quarters > 1 > income Statement > operating Income

-5700000

Quarters > 1 > income Statement > interest Expense

3037000

Quarters > 1 > income Statement > pretax Income

-9055000

Quarters > 1 > income Statement > net Income

-8847000

Quarters > 1 > income Statement > eps

-0.2787604132233202

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

31736931

Quarters > 1 > income Statement > income Tax Expense

2000

Quarters > 1 > income Statement > EBITDA

-5737000

Quarters > 1 > income Statement > operating Margin

-555.5555555555555

Quarters > 1 > income Statement > total Other Income Expense Net

-3355000

Quarters > 1 > balance Sheet > cash

2341000

Quarters > 1 > balance Sheet > short Term Investments

-86000

Quarters > 1 > balance Sheet > receivables

1564000

Quarters > 1 > balance Sheet > inventories

-1564000

Quarters > 1 > balance Sheet > total Current Assets

4520000

Quarters > 1 > balance Sheet > property Plant Equipment

120000

Quarters > 1 > balance Sheet > total Assets

4823000

Quarters > 1 > balance Sheet > payables

1212000

Quarters > 1 > balance Sheet > short Term Debt

6889000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

53901000

Quarters > 1 > balance Sheet > equity

-49105000

Quarters > 1 > cash Flow > net Income

-8847000

Quarters > 1 > cash Flow > depreciation

282000

Quarters > 1 > cash Flow > change In Working Capital

-546000

Quarters > 1 > cash Flow > cash From Operations

-7811000

Quarters > 1 > cash Flow > capital Expenditures

7811000

Quarters > 1 > cash Flow > cash From Investing

32000

Quarters > 1 > cash Flow > cash From Financing

2525000

Quarters > 1 > cash Flow > net Change In Cash

-5256000

Quarters > 1 > ratios > PE

-0.2787604132233202

Quarters > 1 > ratios > PB

-0.14574234681804296

Quarters > 1 > ratios > ROE

18.01649526524794

Quarters > 1 > ratios > ROA

-183.43354758449098

Quarters > 1 > ratios > FCF

-15622000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-15.226120857699804

Quarters > 1 > health Score

29

Quarters > 2 > quarter

2023-06-30

Quarters > 2 > income Statement > revenue

955000

Quarters > 2 > income Statement > cost Of Revenue

17877000

Quarters > 2 > income Statement > gross Profit

-16922000

Quarters > 2 > income Statement > operating Expenses

-16574000

Quarters > 2 > income Statement > operating Income

-348000

Quarters > 2 > income Statement > interest Expense

3111000

Quarters > 2 > income Statement > pretax Income

-26591000

Quarters > 2 > income Statement > net Income

-26243000

Quarters > 2 > income Statement > eps

-0.8268915478941552

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

31736931

Quarters > 2 > income Statement > income Tax Expense

-348000

Quarters > 2 > income Statement > EBITDA

-6557000

Quarters > 2 > income Statement > operating Margin

-36.439790575916234

Quarters > 2 > income Statement > total Other Income Expense Net

-26243000

Quarters > 2 > balance Sheet > cash

7597000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

1414000

Quarters > 2 > balance Sheet > inventories

0

Quarters > 2 > balance Sheet > total Current Assets

11681000

Quarters > 2 > balance Sheet > property Plant Equipment

892000

Quarters > 2 > balance Sheet > total Assets

12807000

Quarters > 2 > balance Sheet > payables

1358000

Quarters > 2 > balance Sheet > short Term Debt

6693000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

54694000

Quarters > 2 > balance Sheet > equity

-41887000

Quarters > 2 > cash Flow > net Income

-26243000

Quarters > 2 > cash Flow > depreciation

16922000

Quarters > 2 > cash Flow > change In Working Capital

-740000

Quarters > 2 > cash Flow > cash From Operations

-9214000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

7000

Quarters > 2 > cash Flow > cash From Financing

3754000

Quarters > 2 > cash Flow > net Change In Cash

-5461000

Quarters > 2 > ratios > PE

-0.8268915478941552

Quarters > 2 > ratios > PB

-0.1708567799197842

Quarters > 2 > ratios > ROE

62.651896769880864

Quarters > 2 > ratios > ROA

-204.9113765909268

Quarters > 2 > ratios > FCF

-9214000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-9.648167539267016

Quarters > 2 > health Score

31

Quarters > 3 > quarter

2023-03-31

Quarters > 3 > income Statement > revenue

477500

Quarters > 3 > income Statement > cost Of Revenue

477500

Quarters > 3 > income Statement > gross Profit

-

Quarters > 3 > income Statement > operating Expenses

11895000

Quarters > 3 > income Statement > operating Income

-11637000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-13121500

Quarters > 3 > income Statement > net Income

-13121500

Quarters > 3 > income Statement > eps

-0.4134457739470776

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

31736931

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-11469500

Quarters > 3 > income Statement > operating Margin

-2437.068062827225

Quarters > 3 > income Statement > total Other Income Expense Net

-1484500

Quarters > 3 > balance Sheet > cash

7597000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

1392000

Quarters > 3 > balance Sheet > inventories

1

Quarters > 3 > balance Sheet > total Current Assets

11681000

Quarters > 3 > balance Sheet > property Plant Equipment

892000

Quarters > 3 > balance Sheet > total Assets

12807000

Quarters > 3 > balance Sheet > payables

4452000

Quarters > 3 > balance Sheet > short Term Debt

8242000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

54694000

Quarters > 3 > balance Sheet > equity

-41887000

Quarters > 3 > cash Flow > net Income

-13121500

Quarters > 3 > cash Flow > depreciation

167500

Quarters > 3 > cash Flow > change In Working Capital

-283000

Quarters > 3 > cash Flow > cash From Operations

-3920500

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

3500

Quarters > 3 > cash Flow > cash From Financing

1190500

Quarters > 3 > cash Flow > net Change In Cash

-2730500

Quarters > 3 > ratios > PE

-0.4134457739470776

Quarters > 3 > ratios > PB

-0.1708567799197842

Quarters > 3 > ratios > ROE

31.325948384940432

Quarters > 3 > ratios > ROA

-102.4556882954634

Quarters > 3 > ratios > FCF

-3920500

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-8.210471204188481

Quarters > 3 > health Score

31

Annuals > 0 > quarter

2023-12-31

Annuals > 0 > income Statement > revenue

1981000

Annuals > 0 > income Statement > cost Of Revenue

1980000

Annuals > 0 > income Statement > gross Profit

1000

Annuals > 0 > income Statement > operating Expenses

28765000

Annuals > 0 > income Statement > operating Income

-28764000

Annuals > 0 > income Statement > interest Expense

6148000

Annuals > 0 > income Statement > pretax Income

-35088000

Annuals > 0 > income Statement > net Income

-35090000

Annuals > 0 > income Statement > eps

-0.9090058700951601

Annuals > 0 > income Statement > dividends Per Share

-

Annuals > 0 > income Statement > shares Outstanding

38602611

Annuals > 0 > income Statement > income Tax Expense

2000

Annuals > 0 > income Statement > EBITDA

-12173000

Annuals > 0 > income Statement > operating Margin

-1451.9939424533063

Annuals > 0 > income Statement > total Other Income Expense Net

-6324000

Annuals > 0 > balance Sheet > cash

2341000

Annuals > 0 > balance Sheet > short Term Investments

-86000

Annuals > 0 > balance Sheet > receivables

509000

Annuals > 0 > balance Sheet > inventories

-1564000

Annuals > 0 > balance Sheet > total Current Assets

4520000

Annuals > 0 > balance Sheet > property Plant Equipment

120000

Annuals > 0 > balance Sheet > total Assets

4823000

Annuals > 0 > balance Sheet > payables

1212000

Annuals > 0 > balance Sheet > short Term Debt

6889000

Annuals > 0 > balance Sheet > long Term Debt

-

Annuals > 0 > balance Sheet > total Liabilities

53901000

Annuals > 0 > balance Sheet > equity

-49105000

Annuals > 0 > cash Flow > net Income

-35090000

Annuals > 0 > cash Flow > depreciation

17319000

Annuals > 0 > cash Flow > change In Working Capital

-1286000

Annuals > 0 > cash Flow > cash From Operations

-13978000

Annuals > 0 > cash Flow > capital Expenditures

17025000

Annuals > 0 > cash Flow > cash From Investing

41000

Annuals > 0 > cash Flow > cash From Financing

3230000

Annuals > 0 > cash Flow > net Change In Cash

-10717000

Annuals > 0 > ratios > PE

-0.9090058700951601

Annuals > 0 > ratios > PB

-0.18473910161897975

Annuals > 0 > ratios > ROE

71.45911821606761

Annuals > 0 > ratios > ROA

-727.55546340452

Annuals > 0 > ratios > FCF

-31003000

Annuals > 0 > ratios > Piotroski FScore

0

Annuals > 0 > ratios > fcf Percent

-15.650176678445229

Annuals > 0 > health Score

30

Annuals > 1 > quarter

2022-12-31

Annuals > 1 > income Statement > revenue

674000

Annuals > 1 > income Statement > cost Of Revenue

672000

Annuals > 1 > income Statement > gross Profit

2000

Annuals > 1 > income Statement > operating Expenses

21892000

Annuals > 1 > income Statement > operating Income

-21890000

Annuals > 1 > income Statement > interest Expense

4309000

Annuals > 1 > income Statement > pretax Income

-31396000

Annuals > 1 > income Statement > net Income

-31398000

Annuals > 1 > income Statement > eps

-1.0798330870652655

Annuals > 1 > income Statement > dividends Per Share

-

Annuals > 1 > income Statement > shares Outstanding

29076716

Annuals > 1 > income Statement > income Tax Expense

2000

Annuals > 1 > income Statement > EBITDA

-28023000

Annuals > 1 > income Statement > operating Margin

-3247.7744807121658

Annuals > 1 > income Statement > total Other Income Expense Net

-9506000

Annuals > 1 > balance Sheet > cash

13058000

Annuals > 1 > balance Sheet > short Term Investments

-193000

Annuals > 1 > balance Sheet > receivables

1062000

Annuals > 1 > balance Sheet > inventories

-

Annuals > 1 > balance Sheet > total Current Assets

16574000

Annuals > 1 > balance Sheet > property Plant Equipment

1323000

Annuals > 1 > balance Sheet > total Assets

34714000

Annuals > 1 > balance Sheet > payables

2938000

Annuals > 1 > balance Sheet > short Term Debt

18221000

Annuals > 1 > balance Sheet > long Term Debt

-

Annuals > 1 > balance Sheet > total Liabilities

52955000

Annuals > 1 > balance Sheet > equity

-18241000

Annuals > 1 > cash Flow > net Income

-31398000

Annuals > 1 > cash Flow > depreciation

555000

Annuals > 1 > cash Flow > change In Working Capital

-3336000

Annuals > 1 > cash Flow > cash From Operations

-21813000

Annuals > 1 > cash Flow > capital Expenditures

23000

Annuals > 1 > cash Flow > cash From Investing

-5000

Annuals > 1 > cash Flow > cash From Financing

2585000

Annuals > 1 > cash Flow > net Change In Cash

-19229000

Annuals > 1 > ratios > PE

-1.0798330870652655

Annuals > 1 > ratios > PB

-0.3745972402828792

Annuals > 1 > ratios > ROE

172.12872101310234

Annuals > 1 > ratios > ROA

-90.44765800541569

Annuals > 1 > ratios > FCF

-21836000

Annuals > 1 > ratios > Piotroski FScore

0

Annuals > 1 > ratios > fcf Percent

-32.397626112759646

Annuals > 1 > health Score

30

Annuals > 2 > quarter

2021-12-31

Annuals > 2 > income Statement > revenue

13397000

Annuals > 2 > income Statement > cost Of Revenue

59000

Annuals > 2 > income Statement > gross Profit

13338000

Annuals > 2 > income Statement > operating Expenses

35801000

Annuals > 2 > income Statement > operating Income

-22462000

Annuals > 2 > income Statement > interest Expense

2950000

Annuals > 2 > income Statement > pretax Income

-23760000

Annuals > 2 > income Statement > net Income

-23762000

Annuals > 2 > income Statement > eps

-0.8296111622746946

Annuals > 2 > income Statement > dividends Per Share

-

Annuals > 2 > income Statement > shares Outstanding

28642334

Annuals > 2 > income Statement > income Tax Expense

2000

Annuals > 2 > income Statement > EBITDA

-22524000

Annuals > 2 > income Statement > operating Margin

-167.66440247816675

Annuals > 2 > income Statement > total Other Income Expense Net

-1298000

Annuals > 2 > balance Sheet > cash

32287000

Annuals > 2 > balance Sheet > short Term Investments

3533000

Annuals > 2 > balance Sheet > receivables

2625000

Annuals > 2 > balance Sheet > inventories

0

Annuals > 2 > balance Sheet > total Current Assets

36337000

Annuals > 2 > balance Sheet > property Plant Equipment

1716000

Annuals > 2 > balance Sheet > total Assets

54889000

Annuals > 2 > balance Sheet > payables

3671000

Annuals > 2 > balance Sheet > short Term Debt

5046000

Annuals > 2 > balance Sheet > long Term Debt

-

Annuals > 2 > balance Sheet > total Liabilities

46683000

Annuals > 2 > balance Sheet > equity

8206000

Annuals > 2 > cash Flow > net Income

-23763000

Annuals > 2 > cash Flow > depreciation

556000

Annuals > 2 > cash Flow > change In Working Capital

1898000

Annuals > 2 > cash Flow > cash From Operations

-16893000

Annuals > 2 > cash Flow > capital Expenditures

49000

Annuals > 2 > cash Flow > cash From Investing

-42000

Annuals > 2 > cash Flow > cash From Financing

9025000

Annuals > 2 > cash Flow > net Change In Cash

-7916000

Annuals > 2 > ratios > PE

-0.8296111622746946

Annuals > 2 > ratios > PB

0.8202471959541798

Annuals > 2 > ratios > ROE

-289.56860833536433

Annuals > 2 > ratios > ROA

-43.291005483794564

Annuals > 2 > ratios > FCF

-16942000

Annuals > 2 > ratios > Piotroski FScore

0

Annuals > 2 > ratios > fcf Percent

-1.2646114801821304

Annuals > 2 > health Score

15

Annuals > 3 > quarter

2020-12-31

Annuals > 3 > income Statement > revenue

6806000

Annuals > 3 > income Statement > cost Of Revenue

551000

Annuals > 3 > income Statement > gross Profit

6806000

Annuals > 3 > income Statement > operating Expenses

36653000

Annuals > 3 > income Statement > operating Income

-29847000

Annuals > 3 > income Statement > interest Expense

1665000

Annuals > 3 > income Statement > pretax Income

-31822000

Annuals > 3 > income Statement > net Income

-31858000

Annuals > 3 > income Statement > eps

-1.1572614742903817

Annuals > 3 > income Statement > dividends Per Share

-

Annuals > 3 > income Statement > shares Outstanding

27528783

Annuals > 3 > income Statement > income Tax Expense

36000

Annuals > 3 > income Statement > EBITDA

-29715000

Annuals > 3 > income Statement > operating Margin

-438.53952394945634

Annuals > 3 > income Statement > total Other Income Expense Net

-1976000

Annuals > 3 > balance Sheet > cash

40203000

Annuals > 3 > balance Sheet > short Term Investments

24616000

Annuals > 3 > balance Sheet > receivables

3179000

Annuals > 3 > balance Sheet > inventories

1

Annuals > 3 > balance Sheet > total Current Assets

45964000

Annuals > 3 > balance Sheet > property Plant Equipment

2224000

Annuals > 3 > balance Sheet > total Assets

65077000

Annuals > 3 > balance Sheet > payables

3065000

Annuals > 3 > balance Sheet > short Term Debt

2637000

Annuals > 3 > balance Sheet > long Term Debt

19507000

Annuals > 3 > balance Sheet > total Liabilities

38198000

Annuals > 3 > balance Sheet > equity

27065000

Annuals > 3 > cash Flow > net Income

-31858000

Annuals > 3 > cash Flow > depreciation

551000

Annuals > 3 > cash Flow > change In Working Capital

291000

Annuals > 3 > cash Flow > cash From Operations

-25749000

Annuals > 3 > cash Flow > capital Expenditures

281000

Annuals > 3 > cash Flow > cash From Investing

52000

Annuals > 3 > cash Flow > cash From Financing

28712000

Annuals > 3 > cash Flow > net Change In Cash

3016000

Annuals > 3 > ratios > PE

-1.1572614742903817

Annuals > 3 > ratios > PB

0.2390269353408461

Annuals > 3 > ratios > ROE

-117.70921854794014

Annuals > 3 > ratios > ROA

-48.95431565683728

Annuals > 3 > ratios > FCF

-26030000

Annuals > 3 > ratios > Piotroski FScore

0

Annuals > 3 > ratios > fcf Percent

-3.824566558918601

Annuals > 3 > health Score

23

Valuation > metrics > PE

-0.16876124295050363

Valuation > metrics > PB

-0.19176999876413825

Valuation > final Score

50

Valuation > verdict

Fair

Profitability > metrics > ROE

14.351815233726173

Profitability > metrics > ROA

-133.12545854732207

Profitability > metrics > Net Margin

-6.2461273666092945

Profitability > final Score

29

Profitability > verdict

Weak

Risk > metrics > Interest Coverage

-1.0770968652922903

Risk > final Score

26

Risk > verdict

High

Liquidity > metrics > Current Ratio

0.3711368277739959

Liquidity > metrics > Quick Ratio

0.3711368277739959

Liquidity > final Score

29

Liquidity > verdict

Weak

Prev Valuations > 0

50

Prev Valuations > 1

50

Prev Valuations > 2

50

Prev Profitabilities > 0

36

Prev Profitabilities > 1

40

Prev Profitabilities > 2

40

Prev Risks > 0

22

Prev Risks > 1

30

Prev Risks > 2

2

Prev Liquidities > 0

48

Prev Liquidities > 1

86

Prev Liquidities > 2

56

Updated At

2026-01-20T22:58:42.848Z

Earnings History > 0 > period

2026-03-31

Earnings History > 0 > report Date

2026-04-20

Earnings History > 0 > date

2026-03-31

Earnings History > 0 > before After Market

BeforeMarket

Earnings History > 0 > currency

-

Earnings History > 0 > eps Actual

-

Earnings History > 0 > eps Estimate

-

Earnings History > 0 > eps Difference

0

Earnings History > 0 > surprise Percent

-